Recall of DePuy Hip Replacement Parts Called Symptom of Medical Device Manufacturers' Rush To Market Without Thorough Testing

Share Article

St. Louis Attorney Jeffrey Singer decries company’s late call for "additional testing" of hip systems, saying that analysis should have been done before 93,000 hip replacement surgeries were performed.

Jeffrey S. Singer

It is unfortunate that a medical device manufacturer would now say their product needs more testing after it has been installed in tens of thousands of patients.

DePuy Orthopaedics’ own recall notice for its hip-replacement systems shows the manufacturer rushed to market with a medical device that has turned out to be defective, St. Louis personal injury attorney Jeffrey S. Singer says.

DePuy announced the recall of its ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System on August 24. The notice on the firm’s website says, “This recall means additional testing and treatment may be necessary to ensure the hip is functioning well.”

“It is unfortunate that a medical device manufacturer would now say their product needs more testing after it has been installed in tens of thousands of patients,” said Singer, the managing partner of Fox, Goldblatt & Singer, P.C., a St. Louis, Missouri-based personal injury law firm that represents victims of dangerous and defective medical devices throughout the country.

“Johnson & Johnson, DePuy Orthopaedics’ parent company, should have done this testing before innocent hip replacement patients were harmed.”

The Wall Street Journal reported that DePuy had sold about 93,000 of the devices before phasing out production last year. The product has been pulled from the market because surgeons have had to replace the medical devices at a rate that is more than twice the industry average.

Patients with the ASR hip replacement parts have experienced pain, difficulty walking, infection and damage to surrounding soft tissue.

“Negligently subjecting patients to the very real possibility of pain, infection and additional surgery is unconscionable,” Singer said. “Repeated surgery is a risk above and beyond the cost and pain.”

The Wall Street Journal article called Johnson & Johnson’s hip-replacement system recall “the latest in a string of products recalled because of quality problems” and said the announcement “deepens concerns about quality controls at the company.”

Days before the hip replacement systems recall, Johnson & Johnson announced a recall of contact lenses in Asia and Europe, according to the article. The same week, the FDA wrote to Johnson & Johnson, saying it was marketing two other joint-replacement products without the required approval from federal regulators.

In April, another Johnson & Johnson subsidiary, McNeil Consumer Healthcare, recalled infant and children's over-the-counter medicines because of "manufacturing deficiencies which may affect quality, purity or potency," according to a May 1 FDA press release.

About Fox, Goldblatt & Singer, P.C.

Established in 1949, the St. Louis, Missouri, personal injury law firm of Fox, Goldblatt & Singer, P.C. has extensive experience with defective drug and medical product cases, as well as car accidents, truck accidents, motorcycle accidents, workers’ compensation law, premises liability and medical malpractice.

The firm serves injury victims throughout the United States, as well as those injured in Missouri and Illinois. For a free consultation, call the firm at (877) 858-4699 or use the firm's convenient online form.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jeffrey S. Singer

Mike Dayton
Visit website